How to Keep Tracking When You Switch GLP-1 Medications

Switching medication is common — for side effects, for coverage, for supply, or because a prescriber wanted to try something else — and it is the point at which more tracking records get abandoned than at any other. The reason is that people treat it as a fresh start, delete or shelve the old log, and begin again.

That instinct is understandable and it is expensive. The value of a record is almost entirely in its length: the question a switch raises is how things compare to before, and you can only answer that if before is still there.

What actually changes at a switch is narrower than it feels. Your dose numbers become non-comparable with the previous ones. Everything else — weight, measurements, symptom frequency and severity, how consistently you take it — carries straight across and stays comparable.

As everywhere in this section, the decision to switch and the plan for it belong to your prescriber. What follows is only about keeping the record intact through it.

On the day of the switch, do a small amount of bookkeeping on the medication you are leaving: record the last dose you took of it, and mark any remaining supply as no longer in use.

This takes two minutes and it prevents two specific muddles. Without a recorded last dose, the boundary between the two medications is fuzzy and any later comparison has an uncertain start point. Without closing off the old supply, a half-used pen or bottle sits in your record as though it were current, which quietly breaks any supply or refill tracking you rely on.

GLP-1 Tracker has a step for this in its switch flow — it offers to stamp the active pen as finished on the switch date, keeping the history so you can still see how long it lasted. On paper, draw a line and write "last dose of X, date" under it.

Do not translate your previous doses into what they would be on the new medication, and do not record a converted figure anywhere in your log.

Different GLP-1 medications are different molecules, and their doses are not on a shared scale — a milligram of one is not comparable to a milligram of another in any way a log should encode. Conversion charts circulate widely and this is one of the few places where doing something that looks helpful actively corrupts your data, because a converted number is indistinguishable from a real one once it is written down.

Record what you were actually prescribed of each medication, under that medication. If you want to see the two side by side, that is fine — as separate series with their own units, which is how GLP-1 Tracker plots them, and it says plainly that milligrams are not directly comparable between molecules. Any question about equivalence is a prescriber question and not a tracking one.

Everything goes in the same record. Past entries stay under the medication they were taken with, new entries go in under the new one, and the switch is a marker on a single continuous timeline.

The alternative — a second app, a second notebook, a second file — is the same mistake as keeping two logs for any other reason, and it has the same result. Within a couple of months you have two partial histories, no way to view them together, and no answer to the only question that mattered.

A good tool handles this without any effort from you: your history stays intact and each medication is attributed correctly. If yours does not, and forces you to erase or restart, that is a strong argument for exporting your data and moving rather than starting a second record.

Record two things: the date the new medication started, and one line on why the switch happened.

The reason is the part people omit and later miss most. In six months you will remember that you switched and have only a vague sense of why — and the reason is exactly what a clinician asks, what determines whether switching back is on the table, and what makes the surrounding data interpretable. "Switched because of persistent nausea at the previous dose" and "switched because insurance stopped covering it" imply completely different readings of the same chart.

Keep it factual and short. You are annotating a record, not making a case. If somebody else made the decision, note whose it was.

On the switch date, take a clean reading of the measures that carry across: a weigh-in under your usual conditions, your body measurements if you take them, and a photo if that is part of your routine.

This gives you a marked starting point for the new medication without breaking the continuity of the old data. You end up able to read the same series two ways — as one long trend, and as before-and-after either side of a dated line — which is exactly what you want when the question is whether anything changed.

This is one of the few genuinely useful pieces of admin at a switch. It costs five minutes on one specific day, and it cannot be reconstructed later.

Do not carry your assumptions about symptoms across the switch. Keep logging the same items so the counts stay comparable, but treat the new medication's pattern as unknown.

The practical version: keep your fixed list of tracked symptoms exactly as it was — changing the list at the same time as the medication would make the two periods incomparable — but stop expecting the old rhythm. If nausea always fell on days two and three before, that tells you nothing about now, and reading the new data through the old expectation is how people convince themselves of patterns that are not there.

It is also worth logging a little more attentively for the first month or so, simply because it is a period you will want to describe accurately. Anything severe or worrying, as always, is a call to your provider at the time rather than an entry to review later.

Add a line to your log at the switch saying that the following few weeks are a transition, and treat what you see in them with corresponding caution.

There are mundane reasons a transition period looks strange in a record. Two medications are being tracked around the same boundary, your routine is being rebuilt, and your own attention to logging is usually higher than normal, which by itself can make symptom counts rise. Any chart that models medication levels will also show something unusual across the boundary — GLP-1 Tracker draws a mixed curve while the previous medication clears, and it is explicit that this is an educational estimate rather than a measurement.

Write the caution down rather than remembering it. In three months the note is what stops you reading a transition artefact as a finding.

A well-kept record across a switch shows what you took, when the change happened, why, and what your own measures did either side of it. Handed to a clinician, that is a genuinely strong basis for a conversation.

It cannot tell you whether the switch is working, whether one medication is better than another for you, or whether to switch again. Those comparisons involve dose equivalence, individual response and clinical judgement, none of which live in a log. GLP-1 Tracker plots each medication as its own curve and states plainly that doses are not comparable between molecules, and it makes no recommendation of any kind.

Bring the record to the person who made the decision, and let the comparison be theirs.